Dr. Reddy's Laboratories Ltd

NSE: DRREDDY · BSE: 500124 · Pharmaceuticals & Biotechnology · 45 announcements

Dr. Reddy's Laboratories Ltd news stories on ALFA NewsRead the news →

Share price: ₹1,203.80
Market cap: ₹1,00,478 Cr
Revenue (annual): ₹33,700 Cr
Net profit (annual): ₹4,196 Cr
P/E (TTM): 31.2×Sector 47.4×
Promoter holding: 26.64%+0.01% QoQ
FII holding: 20.67%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

14 Apr 2026 21:10 IST BSE

Dr. Reddy's Laboratories Legal & Regulatory

Dr. Reddy's Laboratories' Russian subsidiary received a final penalty of ₹1.14 Crore (RUB 9.27 million) from the Russian Tax Authority. The penalty relates to VAT re-classification of marketing services. The company stated this fine has no material impact on its financials or operations.

Value: ₹1.14 Cr

Read the filing ↗